122 related articles for article (PubMed ID: 3354214)
1. [Combinations of anti-arrhythmia agents and the heart conduction system].
Pleskot M; Tilser P; Pidrman V
Vnitr Lek; 1988 Jan; 34(1):23-30. PubMed ID: 3354214
[No Abstract] [Full Text] [Related]
2. [The effect of ajmaline and amiodarone on the heart conduction system].
Pleskot M; Tilser P; Pidrman V
Vnitr Lek; 1986 Feb; 32(2):165-72. PubMed ID: 3962197
[No Abstract] [Full Text] [Related]
3. [Electrophysiologic study of antiarrhythmic agents in man].
Puech P
Arch Inst Cardiol Mex; 1977; 47(2):233-47. PubMed ID: 901058
[No Abstract] [Full Text] [Related]
4. [Effect of various anti-arrhythmia and sympathomimetic agents on the myocardial stimulus threshold in man].
Diewitz M; Baldus O
Arzneimittelforschung; 1973 Apr; 23(4):511-4. PubMed ID: 4740228
[No Abstract] [Full Text] [Related]
5. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat.
Diederich KW; Boyksen D
Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225
[No Abstract] [Full Text] [Related]
6. The effects of N-propyl-ajmaline hydrogen tartrate (NPAB), SPARTEINE SULFATE (SPARteine) and NPAB + sparteine on ECG and aconitine arrhythmias of SIV-rats.
von Philipsborn G
Arzneimittelforschung; 1973 Dec; 23(12):1729-33. PubMed ID: 4801683
[No Abstract] [Full Text] [Related]
7. Changes of refractory periods in the A-V conduction system induced by antiarrhythmic drugs. A study using His bundle recordings.
Schlepper M; Neuss H
Acta Cardiol; 1974; Suppl 18():269-77. PubMed ID: 4547475
[No Abstract] [Full Text] [Related]
8. Combination antiarrhythmic therapy: 1 + 1 > 2?
Tang L
J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1098-100. PubMed ID: 18554208
[No Abstract] [Full Text] [Related]
9. Autonomic tone attenuates drug-induced QT prolongation.
Smith AH; Norris KJ; Roden DM; Kannankeril PJ
J Cardiovasc Electrophysiol; 2007 Sep; 18(9):960-4. PubMed ID: 17666066
[TBL] [Abstract][Full Text] [Related]
10. Influence of various antiarrhythmic drugs (Aprindine, ajmaline, verapamil, oxprenolol, orciprenaline) on functional properties of accessory A-V pathways.
Neuss H; Schlepper M
Acta Cardiol; 1974; Suppl 18():279-88. PubMed ID: 4547643
[No Abstract] [Full Text] [Related]
11. ST-segment elevation in a patient receiving flecainide.
Chung-Esaki H; Tabas J; Goldschlager N
Arch Intern Med; 2011 Jan; 171(1):11-3. PubMed ID: 21220653
[No Abstract] [Full Text] [Related]
12. [Letter: Cardiac automatism].
Porciello PI; Domenichelli B
G Ital Cardiol; 1973; 3(3):452-6. PubMed ID: 4766980
[No Abstract] [Full Text] [Related]
13. [Anti-arrhythmic drugs and heart conduction].
Furlanello F
G Clin Med; 1973 Jul; 54(7):382-406. PubMed ID: 4779853
[No Abstract] [Full Text] [Related]
14. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone].
Makai A; Rudas L; Liszkai G; Fazekas T
Orv Hetil; 2003 Feb; 144(5):241-7. PubMed ID: 12647553
[TBL] [Abstract][Full Text] [Related]
15. [Atrial remodeling and anti-remodeling therapy in atrial fibrillation].
Neumann T; Hölschermann H
Dtsch Med Wochenschr; 2006 Apr; 131(16):884-7. PubMed ID: 16625482
[No Abstract] [Full Text] [Related]
16. Impact of amiodarone on electrophysiologic properties of pulmonary veins in patients with paroxysmal atrial fibrillation.
Rostock T; Servatius H; Risius T; Ventura R; Weiss C; Meinertz T; Willems S
J Cardiovasc Electrophysiol; 2005 Jan; 16(1):39-44. PubMed ID: 15673385
[TBL] [Abstract][Full Text] [Related]
17. [Antiarrhythmic, cardiovascular and toxic effects of 4-[3'-diethylamino-2'-hydroxypropyl]-ajmaline (Tachmalcor) in comparison with ajmaline and propranolol].
Terhaag B; Förster W; Mest HJ; Schrör K
Pharmazie; 1976; 31(1):39-44. PubMed ID: 1257278
[No Abstract] [Full Text] [Related]
18. Why amiodarone is better: another piece of the puzzle.
Murray KT
J Cardiovasc Electrophysiol; 2009 Jul; 20(7):811-2. PubMed ID: 19460071
[No Abstract] [Full Text] [Related]
19. [Value of recording the bundle of His potential with pharmacodynamic tests in heart conduction disorders].
Di Matteo J; Vacheron A; Guize L; Meilhac B; Heulin A; Le Pailleur C
Ann Med Interne (Paris); 1974 Apr; 125(4):371-6. PubMed ID: 4433099
[No Abstract] [Full Text] [Related]
20. [Use of bonnecor in ischemic heart disease].
Gorshkov VA; Nesvetov VN; Chestukhin VV; Narynskiĭ AK; Kesarev GV; Solov'eva FV; Orlov VN; Ianitskaia MV; Solodukhina IS
Sov Med; 1990; (6):72-4. PubMed ID: 2396129
[No Abstract] [Full Text] [Related]
[Next] [New Search]
